Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge-Reference-Cited by-同舟云学术

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge

Published:2022-07-14 Issue:7 Volume:5 Page:e2220957
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Huang David T.¹²³,McCreary Erin K.⁴,Bariola J. Ryan⁴,Minnier Tami E.⁵,Wadas Richard J.³,Shovel Judith A.⁵,Albin Debbie⁶,Marroquin Oscar C.⁷,Kip Kevin E.⁷,Collins Kevin⁷,Schmidhofer Mark⁸,Wisniewski Mary Kay⁵,Nace David A.⁹,Sullivan Colleen¹¹⁰,Axe Meredith³,Meyers Russell³,Weissman Alexandra³,Garrard William⁷,Peck-Palmer Octavia M.¹¹,Wells Alan¹¹,Bart Robert D.²¹²,Yang Anne¹³,Berry Lindsay R.¹⁴,Berry Scott¹⁴,Crawford Amy M.¹⁴,McGlothlin Anna¹⁴,Khadem Tina¹⁰,Linstrum Kelsey¹¹⁰,Montgomery Stephanie K.¹¹⁰,Ricketts Daniel¹,Kennedy Jason N.¹²,Pidro Caroline J.¹,Nakayama Anna¹⁰,Zapf Rachel L.⁵,Kip Paula L.⁵,Haidar Ghady⁴,Snyder Graham M.⁴,McVerry Bryan J.¹⁵,Yealy Donald M.³,Angus Derek C.¹²¹⁰,Seymour Christopher W.¹²¹⁰

Affiliation:

1. Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

2. Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

3. Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

4. Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

5. Wolff Center, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania

6. Supply Chain Management/HC Pharmacy, UPMC, Pittsburgh, Pennsylvania

7. Clinical Analytics, UPMC, Pittsburgh, Pennsylvania

8. Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

9. Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

10. Health System Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania

11. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

12. Health Services Division, UPMC, Pittsburgh, Pennsylvania

13. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

14. Berry Consultants, Austin, Texas

15. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794210/huang_2022_oi_220601_1657213548.90645.pdf

Reference19 articles.

1. Optimizing the trade-off between learning and doing in a pandemic.;Angus;JAMA,2020

2. Fusing randomized trials with big data: the key to self-learning health care systems?;Angus;JAMA,2015

3. Establishing a distribution network for COVID-19 monoclonal antibody therapy across a large health system during a global pandemic.;Bariola;Open Forum Infect Dis,2021

4. Association of subcutaneous or intravenous administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in adults with COVID-19.;McCreary;JAMA Netw Open,2022

5. Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.;McCreary;Contemp Clin Trials,2022

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guideline supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2024-09-10

2. Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity-matched retrospective cohort study of a pan-provincial program in Alberta, Canada;International Journal of Infectious Diseases;2024-09

3. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case;Microbiology Spectrum;2024-08-06

4. Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort;Heliyon;2024-08

5. Sotrovimab in the treatment of coronavirus disease-2019 (COVID-19): a systematic review and meta-analysis of randomized clinical trials;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-20